The Northeast Glucose Drift: Stratification of Post-breakfast Dysglycemia Among Predominantly Hispanic/Latino Adults At-risk or with Type 2 Diabetes
Overview
Authors
Affiliations
Background: There is minimal experience in continuous glucose monitoring (CGM) among underserved racial/ethnic minority populations with or at risk of type 2 diabetes (T2D), and therefore a lack of CGM-driven insight for these individuals. We analyzed breakfast-related CGM profiles of free-living, predominantly Hispanic/Latino individuals at-risk of T2D, with pre-T2D, or with non-insulin treated T2D.
Methods: Starting February 2019, 119 participants in Santa Barbara, CA, USA, (93 female, 87% Hispanic/Latino [predominantly Mexican-American], age 54·4 [±12·1] years), stratified by HbA levels into (i) at-risk of T2D, (ii) with pre-T2D, and (iii) with non-insulin treated T2D, wore blinded CGMs for two weeks. We compared valid CGM profiles from 106 of these participants representing glucose response to breakfast using four parameters.
Findings: A "northeast drift" was observed in breakfast glucose responses comparing at-risk to pre-T2D to T2D participants. T2D participants had a significantly higher pre-breakfast glucose level, glucose rise, glucose incremental area under the curve (all < 0·0001), and time to glucose peak ( < 0·05) compared to pre-T2D and at-risk participants. After adjusting for demographic and clinical covariates, pre-breakfast glucose and time to peak ( < 0·0001) were significantly associated with HbA. The model predicted HbA within (0·55 0·67)% of true laboratory HbA values.
Interpretation: For predominantly Hispanic/Latino adults, the average two-week breakfast glucose response shows a progression of dysglycemia from at-risk of T2D to pre-T2D to T2D. CGM-based breakfast metrics have the potential to predict HbA levels and monitor diabetes progression.
Funding: US Department of Agriculture (Grant #2018-33800-28404), a seed grant from the industry board fees of the NSF Engineering Research Center for Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) (Award #1648451), and the Elsevier foundation.
Moreira F, Reis C, Gallassi A, Moreira D, Welker A PLoS One. 2024; 19(10):e0311501.
PMID: 39383145 PMC: 11463819. DOI: 10.1371/journal.pone.0311501.
Pai R, Barua S, Kim B, McDonald M, Wierzchowska-McNew R, Pai A J Diabetes Sci Technol. 2024; :19322968241274800.
PMID: 39311452 PMC: 11571632. DOI: 10.1177/19322968241274800.
Barua S, Glantz N, Larez A, Bevier W, Sabharwal A, Kerr D Sci Rep. 2024; 14(1):2915.
PMID: 38316854 PMC: 10844336. DOI: 10.1038/s41598-024-52461-1.
Pai A, Santiago R, Glantz N, Bevier W, Barua S, Sabharwal A NPJ Digit Med. 2024; 7(1):7.
PMID: 38212415 PMC: 10784546. DOI: 10.1038/s41746-023-00985-7.
Sato Imuro S, Sabharwal A, Conneely C, Glantz N, Bevier W, Barua S Heliyon. 2023; 9(8):e18440.
PMID: 37533982 PMC: 10391944. DOI: 10.1016/j.heliyon.2023.e18440.